Federal contract award
75N93020F00001
IDT BIOLOGIKA BASE FY20 PROCESS DEVELOPMENT FOR VACCINE CANDIDATES INCLUDING SARS COV 2 CAN 8044363 TOTAL $20,462.00
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | 75N93018D00011 |
| Set-aside | Not reported |
| Pricing type | FIXED PRICE LEVEL OF EFFORT |
| Obligations | $20.5K |
| Current contract value | $20.5K |
| Potential contract value / ceiling | $20.5K |
| Start date | May 8, 2020 |
| Current end date | Apr 17, 2024 |
| Potential end date | Apr 17, 2024 |
| Latest award activity | Apr 22, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 22, 2025 | P00001 | $0 | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI TO FULLY TERMINATE THIS CONTRACT FOR CONVENIENCE, EFFECTIVE APRIL 17, 2025, PURSUANT TO 52.249-2 TERMINATION FOR CONVENIENCE |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.